期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 52, 期 20, 页码 6489-6493出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm900908p
关键词
-
资金
- American Lebanese Syrian Associated Charities (ALSAC)
- Children's Research Hospital, National Institute of Allergy and Infectious Diseases [AI35707]
- Drugs for Neglected Diseases initiative
- Sandler Family Supporting Foundation
The trypanosomal cathepsin TbcatB is essential for parasite survival and is an attractive therapeutic target. Herein we report the structure-guided development of TbcatB inhibitors with specificity relative to rhodesain and human cathepsins B and L. Inhibitors were tested for enzymatic activity, trypanocidal activity; and general cytotoxicity. These data chemically validate TbcatB as a drug target and demonstrate that it is possible to potently and selectively inhibit TbcatB relative to trypanosomal and human homologues.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据